Navigation Links
Allied Minds Launches Novel Disinfectant/Disinfestant Technology Start-up With UC Davis
Date:6/30/2008

Investment Firm, Allied Minds, Establishes New Company to Commercialize

Novel Technology from UC Davis

BOSTON, June 30 /PRNewswire/ -- Allied Minds, a pre-seed investment firm specializing in early stage university business ventures, has established RF Biocidics, Inc., to develop and commercialize a novel disinfectant and disinfestant technology invented at UC Davis.

The newly formed RF Biocidics, Inc. is developing a novel "cleantech" approach using radio frequency (RF) heating to eliminate pathogens and insects without the use of dangerous chemicals or radiation. Traditional efforts to disinfect and disinfest food and agricultural products, have primarily utilized chemical, heat, or radiation inputs with often undesirable results. These methods have inherent problems: 1) toxins are introduced into the food chain and the environment; 2) permanent changes occur in the sensory and nutritional quality of most produce; and 3) radiation drives high the cost of handling and holds a negative consumer perception.

RF heating resolves these issues by delivering lethal energy to insects and microbes without disturbing or damaging the host material or leaving behind any molecules. In general, RF heating eliminates surface heating, reducing thermal loads and allowing a food's quality and nutritional attributes to be maintained. RFB technology is being developed by Professor Manuel Lagunas-Solar of UC Davis.

"We look forward to exploring the many potential applications this technology will encompass. We see benefits in food safety, agriculture, medical sterilization, and as an anti-bioterrorism measure, among others," said Allied Minds COO Marc Eichenberger.

The initial funding for RF Biocidics is being provided by Allied Minds. To learn more about RF Biocidics, please visit http://www.rfbiocidics.com .

About Allied Minds, Inc.

Allied Minds is a seed investment company creating partnerships with key universities to fund corporate spinouts resulting from successful early stage technology research. By providing corporate development support as well as finance, Allied Minds aims to guide early stage companies to commercial success, thereby generating value for all stakeholders. For addition information, logon to http://www.alliedminds.com .


'/>"/>
SOURCE Allied Minds, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
2. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
3. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
4. Glycominds Appoints Board of Directors Chairman
5. Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
6. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
7. Novozymes Launches Enzyme to Reduce Acrylamide in Food
8. Enova Medical Launches Exos Corporation
9. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
10. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
11. ThirdBiotech Networking Group Launches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 02, 2016 , ... ... -operated small businesses in federally funded research and development is welcome news for ... optics and photonics . , As part of the National Defense Authorization Act ...
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation of ... lumbar disc production, company President, Jake Lubinski will be traveling to Switzerland from ... disc in Bern, Lucerne, and Zurich to discuss the benefits of a viscoelastic ...
(Date:12/2/2016)... , Dec. 2, 2016 CytRx Corporation ... development company specializing in oncology, today announced the appointment ... sarcoma surgeon, industry consultant, and private healthcare investor, to ... a healthcare leader with clinical and strategic experience at ... CytRx,s Chairman and CEO. "As one of the world,s ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ... pneumatic tube systems for North American hospitals, will present its chain-of-custody solution for ... and Exhibition in Las Vegas, Nev., Dec. 4-8, 2016. , Aerocom has a ...
Breaking Biology Technology:
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... The report forecasts the biometrics ... a CAGR of 12.28% during the period 2016-2020. ... with inputs from industry experts. The report covers the market landscape ... includes a discussion of the key vendors operating in this market. ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
Breaking Biology News(10 mins):